D
Apogee Therapeutics, Inc. APGE
$39.94 $1.614.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 49.01M 41.55M 35.82M 29.84M 24.58M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 216.87M 178.14M 143.76M 118.53M 93.00M
Operating Income -216.87M -178.14M -143.76M -118.53M -93.00M
Income Before Tax -182.13M -146.66M -118.49M -103.55M -83.99M
Income Tax Expenses 18.00K -- -- -- --
Earnings from Continuing Operations -182.15 -146.66 -118.49 -103.55 -83.99
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -182.15M -146.66M -118.49M -103.55M -83.99M
EBIT -216.87M -178.14M -143.76M -118.53M -93.00M
EBITDA -216.68M -140.88M -82.24M -38.15M --
EPS Basic -3.28 -2.76 -2.40 -5.58 -7.44
Normalized Basic EPS -2.05 -1.72 -1.50 -3.49 -4.65
EPS Diluted -3.28 -2.76 -2.40 -5.58 -7.44
Normalized Diluted EPS -2.05 -1.72 -1.50 -3.49 -4.65
Average Basic Shares Outstanding 220.75M 211.89M 196.33M 144.81M 99.63M
Average Diluted Shares Outstanding 220.75M 211.89M 196.33M 144.81M 99.63M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings